Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 5.
Published in final edited form as: Neurosci Bull. 2015 Feb 6;31(1):141–159. doi: 10.1007/s12264-014-1495-3

Genetics and Epigenetics of Circadian Rhythms and Their Potential Roles in Neuropsychiatric Disorders

Chunyu Liu 1,2, Michael Chung 2
PMCID: PMC4821655  NIHMSID: NIHMS657464  PMID: 25652815

Abstract

Circadian rhythms alterations have been implicated in multiple neuropsychiatric disorders, particularly sleep-wake disorders, addiction, and anxiety and mood disorders. Circadian rhythms are known to be maintained by a set of classic clock genes that form complex mutual and self regulatory loops. While many other genes showing rhythmic expression have been identified through genome-wide studies, their roles in the circadian regulation remain largely unknown. In attempts to directly connect circadian rhythms and neuropsychiatric disorders, genetic studies have identified genes with mutations associated with several rare forms of sleep disorders or sleep-related traits. Other than that, genetic studies of circadian genes in psychiatric disorders have yielded limited success. As important mediator of environmental factors and regulators of circadian rhythms, the epigenetic system may hold the key to the etiology or pathology of psychiatric disorders, their subtypes or endophenotypes. Epigenomic regulations of the circadian system and its related changes have not been thoroughly explored in the context of neuropsychiatric disorders. We argue for systematic investigation of the circadian system, particularly epigenetic regulation, and its involvement in neuropsychiatric disorders, to improve our understanding of human behavior and disease etiology.

Introduction

Circadian rhythms are endogenous biological cycles that are approximately 24 hours in length. They are found in most living organisms, and can be adjusted by factors called zeitgebers, or “time-givers”, including light[1], temperature[2], diet[3], odor[4], and gravity[5], with light being the dominant cue. Maintaining a rhythmic daily life is critical for a living organism to survive the recurrent environmental changes on Earth. These rhythms can be easily observed in behaviors such as sleeping and eating, but also, less visibly, affect crucial biological systems such as metabolism[6;7] and the cardiovascular[7] system.

Multiple evidence have suggested the potential roles of circadian rhythms in neuropsychiatric disorders such as sleep disorders, anxiety, mood disorders and addiction, Meanwhile, studies in animal models have identified several regulators and effectors of the endogenous clock. These core clock genes are known to exhibit transcriptional-translational auto-regulatory complexes. However, these remain insufficient to explain all our observations, especially the contribution to human behavior traits and disorders. Further identification of molecular components of circadian systems and their regulatory relationships is an important step for understanding neuropsychiatric disorders for better diagnostics and treatment.

This review will describe the current findings of genetic and epigenetic determinants of the circadian system in the context of neuropsychiatric disorders. Through reviewing literature, we will highlight the complexity of circadian regulation beyond the classic core clock genes. Such complexity involves many genetic and epigenetic factors. Since epigenetic mechanisms are important mediators of environmental factors and regulators of rhythmic gene expression, we therefore propose that developing comprehensive genome-wide and epigenome-wide data from multiple sample sources will improve our understanding of circadian regulatory system and its role in neuropsychiatric disorders.

Clock genes, rhythmic expression, and regulatory networks

Circadian rhythms in vertebrates are controlled by a conserved brain region at the anterior hypothalamus called the suprachiasmatic nucleus (SCN), made up of about 20,000 neurons. The SCN serves as a central regulator of circadian rhythms throughout the rest of the brain[8] and the body[9]. At the same time, peripheral tissues, even cultured cells[10;11] have their own local, autonomous clocks that can be self-sustaining, but they may be synchronized by the signals from the SCN[12].

Clock genes, underlying circadian rhythms, can be broadly defined as genes that show diurnal variation of activity or function, typically showing rhythmic changes of transcript abundance, as such measure is currently more accessible than other molecular phenotypes, such as protein levels and activities. Although an increasing number of genes have been found to demonstrate circadian characteristics of clock-controlled genes (or CCGs), a small set of genes is denoted here as core “classic clock genes (CG)”. The CGs include Period (PER), Timeless (TIM), Clock (CLK), Cycle (CYC, a Drosophila gene, with mammal homolog ARNTL or BMAL1), Cryptochrome (CRY), REV-ERBalpha, retinoic acid related-orphan receptor alpha (RORalpha), D-box-binding protein (DBP), thyrotroph embryonic factor (TEF), hepatic leukemia factor (HLF), E4BP4 (also known as NFIL3), deleted in esophageal cancer 1 (DEC1), DEC2, Neuronal PAS domain-containing protein 2 (NPAS2), and Double Time (DBT, a Drosophila gene, with mammal homolog casein kinase 1e, CSNK1E). These genes have been mostly identified through screening of mutants of fruit flies, mice and hamsters[13]. These few CGs make up a group of auto-regulatory loops and present rhythmic expression of their own and their regulatory target transcripts. The CGs have been frequently called clock genes in the literature but as will be discussed in this review, these CGs only represents a small set of a much broader network of clock genes.

Most of the CGs encode proteins that function as transcription factors to drive rhythmic expression of their target genes. Some of the CG proteins form heterodimer complexes, such as PER-CRY, CLK- BMAL1, and TIM-PER. They not only regulate expressions of many other genes that carry E-box promoters, but also their own expressions. In contrast, DBP, HLF, TEF and E4BP4 regulate through D-box promoters[14;15]; while the REV-ERBalpha and ROR family members bind to the REV-ERB/ROR response element (RRE)[16]. cAMP response elements (CREs) is another central regulatory motif that mediates rhythmic expression[17]. These regulatory systems have been thoroughly reviewed by several papers[13;1820].

In addition to CGs, hundreds of non-CG genes have been shown to transcribe rhythmically. They are part of the broadly defined clock genes. In fact, one would expect that genes carrying E-box, D-box, RRE and CRE promoter could be potential clock genes[21;22]. Certainly, these genes could include both drivers and passengers of a large circadian regulatory system, though most of the cause-effect relationships still remain to be discovered. Increasing number of CGs have been identified through genome-wide expression profiling studies, mostly in mice, as summarized in Table 1. Just to name a few, 2 to 10% of genes were expressed in a circadian manner in various mouse tissues[2328]; in mouse SCN, 337 genes were found to be expressed cyclically, while 335 were in the liver[26]. Another mouse study detected 575 genes in liver and 462 genes in heart with circadian expressions[27].

Table 1.

list of genome-wide study of genetics, epigenetics of circadian rhythms

Author, Year Species Tissues Measure Strains Microarray/Methods
McDonald MJ et al. 2001[153] Drosophila Head Expression clock mutant (Clk) flies Affymetrix array
Hughes ME et al. 2012[135] Drosophila Brain Expression Wild-type Canton-S flies, y w, per0, and per0 in a Canton-S background RNA-Seq, 100-bp paired-end reads. On average, each sample more than 40 million reads
Kornmann B et al. 2001[24] Mouse Liver Expression C57BL/6 X 129/SV ADDER (Amplification of Double-stranded cDNA End Restriction fragments) differential display
Ueda et al. 2002[154] Mouse SCN and liver Expression Balb/c Affymetrix U74Av2 and U74A oligonucleotide array
Akhtar RA et al. 2002[23] Mouse Liver Expression Custom-made cDNA microarray
Panda S et al. 2002[26] Mouse SCN and liver Expression male C57BL/6J and Clock mutant Affymetrix mouse (U74A) high-density arrays
Storch KF et al. 2002[27] Mouse liver and heart Expression C57/Bl6 Affymetrix U74Av2 oligonucleotide array
Zvonic et al. 2006[155] Mouse Liver and brown and white adipose tissue Expression AKR/J Mouse430a2
Oster et al. 2006[156] Mouse adrenal gland Expression C57BL/6J Mouse4302
Lemos et al. 2006[157] Monkey (macaca mulatta) adrenal gland Expression Affymetrix U133-A GeneChips.
Zvonic et al. 2007[158] Mouse calvarial bone Expression AKR/J Mouse430a2
Yang et al. 2007[159] Mouse prefrontal Cortex Expression C57BL/6J Mouse4302
Maret et al. 2007[160] Mouse whole brain Expression C57BL/6J, AKR/J, DBA/2J Mouse4302
Bray et al. 2007[161] Mouse atrium and ventricle Expression cardiomyocyte-specific circadian clock mutant IlluminaMousev1
Miller et al. 2007[25] Mouse Liver, Skeletal Muscle, gastrocnemius Expression male C57BL/6J and Clock mutant Custom-made genome arrays
Storch KF et al. 2007[28] Mouse Retina Expression male CBA/CaJ Affymetrix mouse 430.2 arrays
Yan J et al. 2008[32] Mouse, human and monkey 14 tissue Expression 22 datasets
Hughes ME et al. 2012[12] Mouse Liver Expression ClockΔ19 mouse Affymetrix Mouse Exon 1.0 ST Arrays
Zambon et al. 2003[162] Human Skeletal muscle Expression Affymetrix U95a
Leonardson AS et al. 2010[29] Human Blood Expression custom array
Li JZ et al. 2013[30] Human 6 different brains areas Expression Affymetrix U133-A or U133Plus-v2 GeneChips.
Lim AS et al. 2014[31] human dorsolateral prefrontal cortex Gene Expression and DNA methylation Illumina Infinium HumanMethylation450k Bead Chip; Illumina HiSeq with 101 bp paired-end reads and 150M reads for the first 12 samples. The remaining samples 50M reads

Human studies have also revealed time-dependent expression in blood and brain. A 2010 study on gene expression induced by food intake identified expression changes associated with biopsy time for 8,197 genes in blood (false discovery rate (FDR) 2.6%)[29]. This is the largest human circadian study thus far, with 40 individuals sampled for 14 time points each, for a total of 560 blood samples. In this study, Li et al. (2013) reported circadian expression in human postmortem brain. They used time of death (TOD) to represent time-points in the 24 hour cycle, turning individual differences into differences of expression at different time points. They analyzed 12,000 transcripts of six different brain areas (dorsolateral prefrontal cortex, anterior cingulated cortex, hippocampus, amygdale, nucleus accumbens, and cerebellum) from 55 controls and 34 major depressive disorder (MDD) patients[30]. Among the healthy controls, more than 417 transcripts in each brain region showed 24-hour oscillations (nominal P < 0.05), while 169 genes have a FDR of <0.5 for combined P values across brain regions. These 169 genes were considered as common circadian genes in the brain[30]. Another study on human postmortem dorsolateral prefrontal cortex samples of 536 subjects used RNA-Seq and global statistics to show rhythmic expression without naming specific clock genes[31].

Most of these rhythmic expressions are tissue-specific, suggesting tissue-specific regulatory network. Only 28 cycling genes were found to be shared between mouse SCN and liver[26], while 37 were shared between mouse liver and heart[27]. Another analysis of 21 microarray data sets from 14 mouse tissues found that the expressions of 41 genes out of 19,168 genes showed consistent circadian oscillation across multiple tissues[32]. This alerts us that study of circadian regulation system should take tissue-specificity into account.

It should be noted that the number of cyclically expressed genes reported is related to the experimental design, statistical method and significance cutoff. With the liberal significance criteria (P < 0.05) used in Li et al.’s human brain study, some of CGs still did not show rhythmicity[30]. However, these findings are not definitive, since many pre- and post-mortem factors could have destroyed rhythmic expression patterns and produced false negatives. Moreover, as transcription factors are typically expressed at low level, major circadian regulators, which are often transcription factors, could be missed by some techniques used in genome-wide studies when sensitivity is not sufficient.

After considering experimental artifacts, the fact that many genes outside of the CGs are rhythmically expressed and that some CGs do not show cycling expression in genome-wide studies could have many different implications, including the possibility that our current list of clock genes may not be exhaustive. Given the complexity of the system, it is likely that we have not yet recovered the complete set of genes regulating and responding to circadian rhythms. Several studies have proposed novel genes as important central regulator genes. For example, a 2008 study of mutant mice proposed that NR3C1 and FKBP/HSP90 complexes are central to the control of circadian gene expression by environmental cues[32]. CHRONO[33;34] and UBE3A[35] were found to be essential in regulating circadian rhythms in mice in three 2014 studies. Genes involving protein translation, including rRNA, also showed rhythmic expression[36]. Furthermore, an siRNA screening on human osteosarcoma cell line, targeting 17,631 known and 4,837 predicted human genes, discovered about 343 clock genes or modulators[37]. These data suggests that the underlying organization of circadian rhythms has not yet been completely described.

Rhythmic expression is certainly not the only aspect of circadian rhythms. Protein abundance and post-translational modifications, such as phosphorylation and ubiquitination, have also been shown to have daily oscillations in Neurospora crassa, fruit fly, and multiple tissues in mouse, rat, and hamster, as reviewed by others[3841]. Similar circadian molecular mechanisms may exist in human, but remain to be explored. From chromatin to transcripts, mRNA to proteins and to protein modifications, circadian rhythms encompasses a complex regulatory system, including the epigenomic components that will be discussed below.

Genetics of sleep-related traits

While circadian patterns can be observed from the molecular level all the way up to the organismal behavior level, the sleep-wake cycle and other sleep-related traits are probably the most salient outputs of the circadian clocks. These traits have been shown to be heritable[44], and underlying genes can be identified directly through genetic methods using human population data, without relying on knowledge of specific known clock genes. The heritability of sleep measures, including timing, duration, and quality, vary between 12.4% and 29.4%[42]. A study of 410 normal adults identified a polymorphism in CLK associated with morningness-eveningness preferences[43]. Furthermore, in a GWAS of 4251 subjects, Allebrandt et al. (2013) identified an intronic variant (rs11046205) in the ABCC9 gene associated with sleep duration (P=3.99e-8)[44].

On the other hand, the circadian system is not the only regulator of sleep. Energy homeostasis and its interactions with circadian also contribute to the maintenance of sleep-wake cycle[45;46]. While homeostasis and other factors play significant roles in sleep regulation, sleep has been used as the major model to study genetics and regulation of circadian rhythms, although it should be noted that genetics of sleep-wake cycle is not necessarily all about circadian rhythms.

Healthy people vary in their preferences of sleep timing and length; some people are often classified as morning lark or evening owl chronotypes. If these variations do not impair quality of life, they are considered normal. Sleep-wake behaviors in human and animal models offer opportunities to understand circadian regulation. In humans, variable sleep traits or disorders provided subjects for studying the molecular bases of sleep regulation, and, by extension, circadian rhythms. In animal models, one can take advantage of better-controlled environmental factors to study their contribution to circadian regulation. For example, manipulating lighting environment and feeding pattern have been shown to induce circadian and related genomic and epigenomic changes[47].

Circadian disruptions are implicated in multiple neuropsychiatric disorders

Disruption of circadian rhythms have been associated or implicated in many traits or diseases, including metabolic syndrome[48], obesity[49], diabetes[50], inflammatory diseases and autoimmune disorders[51], cancer[52], drug efficacy and toxicity[53], cardiovascular disorders[54], and mental disorders[55;56].

Among neuropsychiatric disorders, sleep-wake disorders, anxiety, mood disorders and addiction have the strongest connections to altered circadian rhythms. While the connection between circadian rhythms and sleep-wake disorder is self-evident, circadian rhythms have been implicated in other non-sleep psychiatric disorders based on biological and clinical observations. Specifically, many of these disorders exhibit co-morbidity with sleep disturbance and their treatments often elicit responses that are related to clock candidate genes, behavioral or clock gene expression changes in animal models. Additional link between circadian rhythms and neuropsychiatric disorders can be found in several candidate gene association studies. Major evidence are summarized in Table 2. A few examples of those indirect evidence linking circadian rhythms to non-sleep neuropsychiatric disorders can be provided as following: abnormal sleep is co-morbid with multiple disorders[57]. Persistent sleep disturbances have been found to increase risk of developing anxiety[58] and depression[59;60]. Insomnia and substance abuse disorders promote risk of each other[60;61]. Melatonin is important in synchronizing circadian rhythms[62], and agomelatine that targets the melatonergic system is an antidepressant [63]; agomelatine has been shown to increase the relative amplitude of an individual’s rest-activity cycles[64]. Ketamine, a drug with rapid-acting antidepressive effects, can influence the recruitment of the CLK-BMAL1 complex to E-box promoters and alter the expressions of CGs[65]. Another antidepressant, escitalopram, was reported to restore the disrupted rhythmic expression of several CGs in a study of blood samples from 12 MDD patients and 12 controls[66]. Animal models with disrupted clock genes show behavioral changes similar to mood disorders[67] or schizophrenia[68]. Therefore, circadian rhythms have been a system of interest in the study of these disorders. However, the question of causation largely remains to be addressed.

Table 2.

Studies That Implicate Circadian Rhythms in Psychiatric Disorders

Mood Disorder (MDD and bipolar disorder) Anxiety Addiction
Sleep disturbance comorbidity, or as risk factor Risk factor for developing MDD[59;60]. Abnormal circadian rhythms in hormone levels, body temperature, sleep, and behavioral patterns reported in patients with MDD[163165]; The degree of circadian misalignment correlated with severity of depression[166]; Sleep disturbance featured in manic and depressive phases, even possibly euthymic phases[167;168]. Risk factor for developing anxiety[58]; children daily regularity predict anxiety levels more than a decade later[169] Bi-directional relationship: addiction disrupt circadian rhythms, sleep and mood problem increase chance of addiction[60;170]
Therapy Seasonal affective disorder (SAD) patients are responsive to light therapy[171]; Sleep deprivation treats depression[172]. Sleep deprivation may switch a depressed patient into hypomania or mania[173]. Agomelatine increase the relative amplitude rest-activity cycles[64]. Lithium lengthen the circadian period in treated hamsters[174]. Agomelatine affects circadian rhythms[64], is also effective in treating anxiety disorders[175;176].
Chronotype Mood disorders associated with chronotype[177;178] Evening chronotype associated with substance abuse[179;180]
Social rhythms disrupted social rhythms[181183] Lower daily regularity in anxiety patients[184]
Seasonal pattern Seasonal changes in bipolar[185;186] A case report for SAD with cyclical cocaine craving[187]
Hormone Rhythmic melatonin level[188;189] Cortisol levels is rhythmic[190] Cortisol secretion patterns linked to addiction[191]
Clock gene genetic association 17 studies of candidate genes[192] One candidate gene study[193] Six genetic studies[194199]
Clock gene in animal model Knockout of REV-ERBalpha was found to increase midbrain dopamine production and induce mania-like behavior through regulating tyrosine hydroxylase (TH) gene expression in a mouse study[200]. Clk mutant shows mania[67] Per1 and Per2 expression levels in the nucleus accumbens were reported to regulate anxiety levels in knockout mouse models and mice experiencing chronic social defeat stress[201]. Clk mutant less anxious[67] Fourteen studies of Clock, per1 and per2 mutant mice showed behavior changes in response to drug[202]
Clock gene expression in response to drug treatment Ketamine influence the expressions of clock genes[65]. Escitalopram restore the disrupted rhythmic expression of several clock genes[203]. Lithium’s effects on expression of multiple clock genes were reported[204207]. Valproic acid changes the phase and amplitude of PER2 expression in cultured cells[117] Anxiolytic medications reduce mPer1 expression in mice[208] chronic methamphetamine treatment desynchronize clock gene expression between straitum and SCN[209]; ethanol and drugs of abuse alter clock gene expression in SCN and other brain regions[202]
Clock gene expression changes in patients Expression changes of clock genes reported in MDD brains[30] and blood[210].
Review Gonzalez 2014[192] Philip Gorwood, 2012[69] Logan RW et al. 2014[202]

A multi-system hypothesis has been formulated to explain the connections between circadian rhythms disturbance and addiction, as well as anxiety. Based on literature review, Gorwood highlighted the cortisol-melatonin-vasopressin interaction for anxiety, as this interaction nicely bridges stress response and circadian systems[69]. Drugs of abuse may influence the interwoven molecular networks of circadian rhythms, stress-response, reward circuitry, neuroplasticity and memory, and ultimately lead to the development of addiction, as well as withdrawal symptoms. The paraventricular nucleus (PVN) in the hypothalamus has been proposed to be the location where circadian and stress signals converge, and where multiple clock genes, neuropeptides, and stress response genes interact[70]. Such interaction between circadian systems and stress response systems may play an important role in multiple psychiatric disorders, including but not limited to addiction[71].

The Dopamine D2 receptor (DRD2) is another interesting candidate linking the circadian system and the reward pathway, as it mediates photic response to regulate circadian rhythms, and the most important reward pathway is dopaminergic [72]. Multiple candidate gene studies have found significant associations between DRD2 variants and different kinds of addiction (alcohol, cocaine, heroin, and nicotine)[73;74]. However, a meta-analysis[75] and a genome-wide association study (GWAS)[76] of alcoholism reported inconsistent results, suggesting that the DRD2 contribution may be small, if at all. DRD2 variant was also reported to be associated with anxiety disorders with co-morbid alcohol use disorder[77]. But the finding is also weak and requires replication.

Circadian genetics of neuropsychiatric disorders

Genetic studies may capture some direct evidence that specific clock genes are involved in neuropsychiatric disorders if mutations or variants of clock genes are associated with risk of disorders. Genetic association is an important venue leading to translation of animal model clues to clinical relevance.

Sleep-wake disorders

Sleep-wake disorders impair quality of life, affect learning, memory, and mood. These disorders have a clear genetic basis. Family and twin studies of insomnia reported heritability ranging between 21% and 58%[7880] (see Palagini et al. (2014) for a thorough review[81]). Travel across time zones, sleep deprivation, and shiftwork all disturb sleep patterns. Insomnia, hypersomnia and narcolepsy are major sleep-wake disorders[82]. Some of these are common, like insomnia (about 10% adults have severe insomnia that cause daytime consequences[83]), and some are rare, like narcolepsy (affecting about 1 in 3,000)[84]. Jet lag and shiftwork-related sleep problems are common in specific occupations, like flight attendants, nurses, and soldiers.

Mutations in genes responsible for some specific, mostly rare forms of sleep disorders have been discovered. A mutation (R192H) in GABRB3 has been found in patients with chronic insomnia. Since GABRB3 encodes a subunit of a chloride channel that serves as the receptor for gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter of the mammalian nervous system, this suggests that a decrease in GABAergic inhibition may contribute to insomnia[85]. Interestingly, hypersomnia was also recently linked to GABA(A) receptor regulation[86]. Another excessive sleeping disorder, narcolepsy, is mostly caused by a deficiency in hypocretin (HCRT), an excitatory neuropeptide[87].

Mutations in PER2 and CSNK1D have been reported in Advanced Sleep Phase Syndrome (ASPS) patients. A rare autosomal dominant mutation of PER2 has been found to be responsible for ASPS in members of a Utah family[88]. CKIdelta (CSNK1D) was found to have a missense mutation responsible for ASPS[89].

Knockout or mutation of many other genes, including IA2[90], have been found to change sleep-related behaviors in mice, and have been reviewed elsewhere[91]. These genes could be candidates for human sleep disorders, but mutations have not been detected in humans so far.

The search for genes of common forms of sleep disorders has produced positive and negative results. A GWAS of insomnia with 2,267 samples did not detect any genome-wide significant association[92]. However, several other sleep disorders have yielded genome-wide significant signals in GWASs with hundreds of cases, including restless legs syndrome (MEIS1, BTBD9, PTPRD, MAP2K5, SKOR1, TOX3, BC034767, MAP2K5, LBXCOR1)[9396] and narcolepsy (TRA-alpha, TRAJ10)[97].

It should be noted that circadian defect is not the only cause of sleep-wake disorders. Cardiovascular, neurological, and pulmonary diseases, use of substance and medication, irregular metabolism, and bad habits all could disturb sleep. One can certainly argue that some of those genes associated with sleep disorders may not be involved in circadian regulation at all. In fact, among the classic clock genes, CGs, only PER2 has been found to carry a mutation (c.1984A>G (p.Ser662Gly)) responsible for a sleep disorder[88]; all the other associated genes are outside of the CGs. Most of them do not have any known connection to circadian regulation, or have not been studied for rhythmic expression. How sleep disorder-associated genes are related to circadian remains to be investigated. It may turn out that some of those non-CG genes are also actual clock genes, participating in circadian regulation.

Non-sleep neuropsychiatric disorders

Genetic variants of candidate genes of CGs, have been tested for association with bipolar disorder[98;99], depression[100], seasonal affective disorder[101;102], or anxiety disorders[77], alcohol use[103], heroin addiction[104], bipolar and schizophrenia[105], major depression and bipolar[106], depression and sleep disorder[107], Though some positive associations were reported, most findings were weak and not replicated.

Genetic associations of about 360 selected clock genes were systematically assessed in 14 psychiatric GWAS data sets based on relaxed thresholds for significance, by McCarthy et al. (2013)[108]. Bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, and MDD as a group of disorders and lithium-responsiveness have been shown to have association signals enriched in 18 core clock genes and genes reported to be rhythmically expressed in more than six mouse tissues. This is the first GWAS evidence supporting potential genetic contributions of circadian system in neuropsychiatric disorders, although the selection of clock gene in this study may be debatable; and replication is warranted.

It is important to note that the CGs did not make any top GWAS signals of these psychiatric disorders, despite the fact that circadian disruption has been strongly implicated in neuropsychiatric disorders. Genetic studies of depression, anxiety, and addiction, have yielded largely negative results[109113]. The study by McCarthy et al. suggested collective weak contributions from clock genes for susceptibility of various disorders. This has multiple implications: First, it is possible that some other non-CG clock genes associated with disease are also part of the circadian system, but have not yet been identified as such. Secondly, clock genes may be more relevant to specific subtypes or endophenotypes of those diseases; therefore, subgroups of those disorders may provide better association with clock genes. Lastly, the circadian system may contribute to disease risk more through a non-genetic route, such as epigenetics.

Epigenetic factors regulate circadian rhythms

When genetics have yielded very limited success in providing direct evidence to link circadian rhythms to neuropsychiatric disorders, epigenetics naturally get our attention as the critical regulators (for gene expression) and mediators (for environmental factors). Then the first questions are whether epigenetic factors regulate circadian rhythms as they should be in theory, and what are those circadian epigenetic factors.

The circadian system is dynamic and flexible, and is tightly regulated by the interactions between internal molecular systems and environmental cues. The environmental factors, including light, food, temperature, stress, hormones, drugs, and age, act through epigenetic factors to shape the phenotypes. Gene expression, as the molecular representatives of circadian rhythms, is known to be regulated by genetic variants and epigenetic factors. Epigenetic factors include DNA methylation, histone modifications (methylation, acetylation, phosphorylation, and citrullination, biotinylation, ribosylation, ubiquitination, palmitoylation etc.), and non-coding RNAs. Studies on histone acetylation, DNA methylation, non-coding RNA, and RNA modification have shed light on their roles in regulating expression of clock genes, and ultimately, circadian phenotypes. With such studies, we could look for circadian epigenetic factors, and further study their contribution to neuropsychiatric disorders.

Acetylation and deacetylation

The epigenetic mechanism that CLK uses to regulate circadian rhythms is histone acetylation and deacetylation. Etchegaray et al (2003) showed in a mouse liver study that histone acetyltransferase (HAT) p300 works with Clock/Bmal1 complex to regulate histone H3 acetylation at the promoters of Cry and Per genes to influence their expressions.[114] Doi et al (2006) further showed that CLK itself possesses HAT activity, which can be enhanced by its partner BMAL1, when bound to E-box [115]. CLK is also involved in acetylating other non-histone substrates including BMAL1. Acetylated BMAL1 recruits CRY1 to CLK-BMAL1 complex and represses transcription[116].

Histone deacetylase (HDAC) has a function opposite to that of HAT, and is also an important regulator of circadian rhythms and memory formation, as well as metabolism. It removes acetyl groups from an ε-N-acetyl lysine on histones, allowing the histones to wrap the DNA more tightly. HDAC inhibitor, Valproic acid (VPA) and trichostatin A (TSA) were found to increased H3 acetylation and affect Per2 expression in an in vitro study[117].

A mouse model has shown that Hdac3, one of the Hdac subtypes, is recruited by nuclear receptor corepressor 1 (Ncor1) and is involved in repressing Bmal1 expression, thus affecting circadian rhythms and metabolism[118]. Hdac3 recruitment also fluctuates rhythmically in the mouse liver, in conjunction with Rev-erb-alpha and Ncor, to form a Hdac3/Rev-erb-alpha/Ncor complex[119]. It is expected that transcriptions of many genes will oscillate with the fluctuation of HDAC3-related histone modification, or Rev-Erb-alpha/NCoR1-related signaling pathways.

Another member of the HDAC family, an NAD(+)-dependent protein deacetylase, SIRT1, also works directly with clock genes. SIRT1 binds CLK-BMAL1 and promotes deacetylation and degradation of the PER2 protein in mice[120]. SIRT1 is also a metabolic sensor, as it requires binding of its coenzyme NAD+ for its HDAC enzymatic activity. Thus, through SIRT1, metabolic states are linked to the circadian system. In addition, SIRT1 has been implicated in aging and neurodegeneration[121;122], synaptic plasticity and memory formation in mouse studies[123;124].

The lysine-specific demethylase, JumonjiC (JmjC) and ARID domain-containing histone lysine demethylase 1a (JARID1a) are also major binding partners of CLK-BMAL1. It can inhibit HDAC1 function and enhance transcription by CLK-BMAL1 in a demethylase-independent manner. CLK-BMAL1 complex plays a conserved circadian regulatory role across insect and mammalian species[125].

DNA methylation

The role of DNA methylation in circadian regulation is supported by a human study in which plasma homocysteine levels and global DNA methylation level showed 24 hour variation in blood of 15 males and 15 females[126]. Homocysteine level has been linked to DNA methylation in multiple studies[127]. An epigenome-wide study by methyl-DNA immunoprecipitation (MeDIP-chip) in mice showed that altered day length changed gene expression profiles and promoter DNA methylation in SCN, suggesting that DNA methylation regulates the circadian clock in SCN[128]. Moreover, a study in mice showed that sleep deprivation can change DNA methylation and hydroxymethylation of hundreds to thousands of CpG sites near genes involving neuritogenesis and synaptic plasticity, cytoskeleton, signaling and neurotransmission[129]. The direct evidence supporting the roles of DNA methylation in regulating circadian rhythms came from a human study, which used global statistics to show evidence of significant 24-hour rhythmicity of DNA methylation, as well as its correlation with rhythmic gene expression in human dorsolateral prefrontal cortex[31].

Non-coding RNA

MicroRNAs (miRNAs), probably the most intensively studied class of non-coding RNAs (ncRNAs) so far, may contribute to the regulation of circadian rhythms. Dicer is the major enzyme in miRNA biogenesis, and Dicer-deficient mice and cells show shorter circadian cycles due to faster translation of PER1 and PER2 proteins. It has been proposed that microRNAs miR-24, miR-29a, and miR-30a may specifically target PER1 and PER2, thus determine the period of the cycle[130].

Studies in mice also implicated miR-134 and miR-132 as two other miRNAs in circadian regulation. miR-134 is brain-specific, and regulated by SIRT1[124]. It is involved in regulation of CREB and BDNF levels, two proteins that are important in many neuronal functions and activities[124]. miR-132 is a direct link between light and chromatin remodeling: it is induced by photic entrainment cues via the mitogen-activated protein kinase (MAPK)–CREB signaling pathway[131] and regulates chromatin remodeling and translation[132].

Other ncRNAs have strong potential in regulating circadian rhythms too. Rhythmic expression was reported for 112 long non-coding RNAs (lncRNAs) in the rat pineal gland, which is the source of melatonin[133], while melatonin is an important hormone timing circadian rhythms. A study of Neurospora gene frequency (frq) proved that lncRNAs could regulate circadian rhythms through anti-sense expression[134]. RNA-Seq of period-null Drosophila identified several ncRNAs with diurnal expression, including a family of small nucleolar RNAs (snoRNA)[135]. It should be noted that some non-coding RNAs, particularly long non-coding RNAs, evolved fast and are species-specific[136;137]. These non-human findings only suggest some possible epigenetic mechanisms that may occur in human. The actual genes in human remain to be discovered.

RNA modification

Post-transcriptional RNA processing and modifications may be relevant to clock function. A recent study in mice and cultured human cells showed that n6-methyladenosine (m6A) RNA-methylation, one of the most common RNA modifications, was involved in circadian clock regulation[138].

Studies also showed that diet could affect epigenetic regulation of circadian function. In a study of Japanese macaques, maternal high-fat diet in utero can disrupt expression regulation, and increase individual variations of fetal hepatic Npas2, one of the CGs. Such disruption was associated with altered histone acetylation (H3K14ac) but not DNA methylation at the Npas2 promoter region. The changes of gene expression and histone modification can be reversed by postnatal diet[139]. Mouse exposed to different length of light a day changed SCN and neuronal Per1 gene expression and behavior after birth[140], suggesting possible epigenetic modification induced by early-life environmental effects, although epigenetics was not part of the study.

The epigenetics of circadian systems is a new emerging research field, leaving a lot to be investigated. Most studies have been performed in mouse models, and only a few in humans. Since differences in epigenetic regulation between mice and humans during pre-implantation development have been observed[141], findings from mice and other species may not translate to humans directly. Moreover, many epigenetic factors, such as hydroxymethylation, long non-coding RNAs, and most of the histone modifications other than acetylation, have not been studied in the context of circadian regulation in humans. Even for those factors studied, the findings are still fragmentary, and do not form one coherent picture of the regulatory system. It is not known whether those factors work independently or interactively to regulate each of the clock genes, or the circadian system as a whole, and how. For these reasons, we are advocating a more comprehensive epigenomic study of the circadian system in humans.

Circadian epigenetics in neuropsychiatric disorders

Although plenty of data has implicated circadian in the risk of neuropsyhicatric disorders, and that epigenetic factors are important regulators of circadian, only very limited studies have been performed to explore the epigenetics changes in neuopsychiatric disorders.

Sleep-related disorders

A few studies have been published on gene expression changes in disturbed sleep. The epigenetic regulation of those changes remains largely unknown as only one candidate gene study exists for DNA methylation.

Möller-Levet et al. studied gene expression profiles and reported that 711 genes were up- or down-regulated in the blood of people suffering from insufficient sleep. The number of genes with a circadian expression profile also reduced from 1,855 to 1,481[142]. This same research group also studied blood transcriptome in desynchrony of sleep-wake timing and circadian rhythms, and identified a dramatic reduction of rhythmic transcripts (6.4% drop to 1.0%) caused by the desynchrony[143]. The chromatin modification and expression regulation pathways were consistently implicated by the differentially expressed genes in these two sleep studies.

Bollatti et al. (2010) studied the effects of daytime and nighttime shiftwork and its effects on global DNA methylation and the methylation of the promoters of three candidate genes (glucocorticoid receptor (GCR), tumor necrosis factor alpha (TNF-alpha), and interferon-gamma (IFN-gamma)) using peripheral blood DNA from 100 shiftworkers and 50 day workers in Northern Italy. A small but significant difference in methylation was detected between morning and evening type shiftworkers in TNF-alpha promoter. However, no significant methylation difference was detected when comparing shiftworkers to day workers[144]. It is noted that all the reported associations or correlations were weak.

Non-sleep neuropsychiatric disorders

Prader-Willi syndrome (PWS) is the first neuropsychiatry disorder with evidence of disrupted circadian epigenomics. PWS is a genetic disorder featured by obesity, intellectual disability and sleep abnormalities. This disorder frequently co-morbid with psychiatric problems[145]. It is caused by a deletion on the paternal chromosome 15q11-q13, considered to be caused by loss of snoRNAs[146], which are processed products of a lncRNA gene, 116HG. Study of mice lacking 116HG showed altered expression of several clock genes and energy use in brain[147].

Another pilot study connecting genetics and epigenetics of clock genes to psychiatric disorders is on miRNA. The precursor of miR-182 was found to carry a SNP rs76481776 that was associated with late insomnia in MDD patients (corrected p <0.00625), in a study of 359 MDD patients and 341 control individuals. CLK is one predicted target of miR-182 and regulation relationship was validated through in vitro assays[148]. This relationship between an SNP, the expression of a miRNA and its targets warrant further investigation. However, it does suggest that we should pay more attention to subtypes or endophenotypes rather than diagnostic classification, when studying genetics and epigenetics of those disorders.

Clearly, circadian epigenomics has not received sufficient attention in study of neuropsychiatric disorders although the circadian rhythms have been one of the major phenotypes to study in these disorders.

Future perspectives

Based on studies reviewed above, we see that knowledge of regulatory systems of circadian rhythms may provide opportunity to understand psychiatric disorders. However, we still have limited understanding of the broader network context of such circadian regulatory systems, particularly the epigenetic aspects of such regulation. Genes involved in circadian rhythms remain to be discovered and organized into network systems. Epigenomics need to be integrated in order to complete the expression regulatory circuitry, and connect with environmental factors. More importantly, considering such regulation and networks in the context of neuropsychiatric disorders would provide new perspectives on the link between circadian and human behaviors, therefore allowing better understanding of disorders.

Understanding the complex biological systems that produce them is necessary to decipher complex traits such as neuropsychiatric disorders[149]. Circadian regulation is a complex biological system. Environmental factors and internal biological infrastructure work together: light acting through photoreceptors, food working through SIRT1-related pathways, and psychological stress through the HPA-neuroendocrine system--all regulate an organism’s internal clock. Serotonergic, dopaminergic, and maybe other neurotransmitters systems interact with circadian regulatory networks to influence human behavior and disorders.

Our current knowledge about circadian rhythms is largely derived from studies of candidate genes, for their biochemistry, genomics and epigenomic regulation. There are very limited genome-wide, systematic studies in human (Table 1). Genome-wide study is critical for obtaining unbiased understanding of biological systems. It is important to put existing knowledge into a biological network, to re-assess all the interactions and signaling connections. Novel components of circadian controls, from its environmental cues to the downstream effectors will be discovered. Several papers have been published to advocate the use of systems biology to study circadian rhythms, and to construct regulatory system of circadian rhythms through integration of multiple -omics[150152].

A complete circadian regulation system should contain every member of the circadian regulation cascades, from the core clock modulators to the downstream effector genes. It should also represent regulators at different levels, from environmental cues to epigenetic factors, RNA and protein modifications. Relationships among these nodes, genes and their interactions are critical parts of the systems. The use of such systems holds the key to understanding of circadian rhythms and its role in neuropsychiatric disorders.

Regulatory systems are spatiotemporally-specific. This suggests that tissue selection is important for the study of circadian rhythms and psychiatric disorders. Brain is the critical organ/tissue for understanding neuropsychiatric traits or disorders, including those that are circadian-related, particularly as the circadian regulation has tissue-specificity. However, other than imaging studies, it is almost impossible to study live human brain for circadian dynamics. Excessive assumptions have to be made in the analyses of human postmortem data. Different individuals could differ by variables other than the time of death. Model animal brains, cultured or induced neuronal cells derived from stem cells, and human blood are a few alternatives that could provide multiple time-point data around clock. However, each model system has its own limitations. Complementary use of these different models may help us build a comprehensive understanding of the regulatory network and its relevance to human circadian-related traits and disorders.

Genomic and epigenomic studies of patient and control samples should also take into account the diurnal variations. Hundreds or even more genes have variable gene expression or epigenetic markers within 24 hours in a day. In the past, the time when data or material was collected has rarely been recorded and incorporated into analyses. As a result, artifacts may have been introduced in some published data unless the sample collection was done at a similar time of a day. Circadian studies in healthy humans will provide critical baseline information for other studies when time of day data are not available.

The findings from genetic and epigenetic studies could lead to novel drug targets. Belsomra, a hypocretin receptor antagonist, was recently approved by FDA as a new drug to treat insomnia. Hypocretin has been connected to sleep-wake cycle since the discovery of a mutation responsible for narcolepsy, though it is not considered part of the CGs. We may have many other drug targets buried in the list of rhythmic expression or epigenetic regulation of circadian rhythms, the complete circadian regulation systems. Epigenetic drugs have big potentials in treating neuropsychiatric disorders. Theoretically, it will be much easier to use drugs to modify the epigenome than to correct mutated genes.

Understanding the genetics and epigenetics of circadian-related traits and diseases will lead to better and more precise diagnosis of circadian-related disorders. Ultimately, it will improve the quality of life for people suffering from disorders, such as jet lag or shiftwork, when we are able to develop epigenetic intervention to ease the pains and discomfort.

Through our review, it is clear that epigenetics may play important roles in regulating circadian rhythms and associated neuropsychiatric disorders, but related studies are lacking today. The circadian cycle is a highly environment-dependent biological process. The circadian cycle is one of the best models to study environmental impact and gene-environment interactions. Much effort should be placed into this interesting research field. Using the circadian-related phenotypes and biomarkers, we may have an exceptional opportunity to access the dark kernel of psychiatric disorders.

Acknowledgments

We thank Ms. Kay Grennan and Dr. Annie Shieh for critical and thoughtful readings of this manuscript. We also thank Dr. Minhan Yi and Ms. Haiyan Tang for proofreading. The review work has been partially funded by NIH R01-ES024988 and U01-MH103340, and Central South University.

Reference List

  • 1.Honma K, Honma S, Wada T. Entrainment of human circadian rhythms by artificial bright light cycles. Experientia. 1987;43 (5):572–574. doi: 10.1007/BF02143589. [DOI] [PubMed] [Google Scholar]
  • 2.Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal resetting cue for mammalian circadian oscillators. Science. 2010;330 (6002):379–385. doi: 10.1126/science.1195262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012;26 (8):3493–3502. doi: 10.1096/fj.12-208868. [DOI] [PubMed] [Google Scholar]
  • 4.Abraham U, Saleh M, Kramer A. Odor is a time cue for circadian behavior. J Biol Rhythms. 2013;28 (1):26–37. doi: 10.1177/0748730412469353. [DOI] [PubMed] [Google Scholar]
  • 5.Fuller CA, Hoban-Higgins TM, Griffin DW, Murakami DM. Influence of gravity on the circadian timing system. Adv Space Res. 1994;14 (8):399–408. doi: 10.1016/0273-1177(94)90431-6. [DOI] [PubMed] [Google Scholar]
  • 6.Bailey SM, Udoh US, Young ME. Circadian regulation of metabolism. J Endocrinol. 2014;222 (2):R75–R96. doi: 10.1530/JOE-14-0200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Morris CJ, Yang JN, Scheer FA. The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res. 2012;199:337–358. doi: 10.1016/B978-0-444-59427-3.00019-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker M, Block GD. Circadian rhythms in isolated brain regions. J Neurosci. 2002;22 (1):350–356. doi: 10.1523/JNEUROSCI.22-01-00350.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res. 2002;309 (1):193–199. doi: 10.1007/s00441-002-0585-0. [DOI] [PubMed] [Google Scholar]
  • 10.Leise TL, Wang CW, Gitis PJ, Welsh DK. Persistent cell-autonomous circadian oscillations in fibroblasts revealed by six-week single-cell imaging of PER2::LUC bioluminescence. PLoS One. 2012;7 (3):e33334. doi: 10.1371/journal.pone.0033334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ruan GX, Allen GC, Yamazaki S, McMahon DG. An autonomous circadian clock in the inner mouse retina regulated by dopamine and GABA. PLoS Biol. 2008;6 (10):e249. doi: 10.1371/journal.pbio.0060249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hughes ME, Hong HK, Chong JL, Indacochea AA, Lee SS, Han M, Takahashi JS, Hogenesch JB. Brain-specific rescue of Clock reveals system-driven transcriptional rhythms in peripheral tissue. PLoS Genet. 2012;8 (7):e1002835. doi: 10.1371/journal.pgen.1002835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wager-Smith K, Kay SA. Circadian rhythm genetics: from flies to mice to humans. Nat Genet. 2000;26 (1):23–27. doi: 10.1038/79134. [DOI] [PubMed] [Google Scholar]
  • 14.Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 2006;4 (1):25–36. doi: 10.1016/j.cmet.2006.04.015. [DOI] [PubMed] [Google Scholar]
  • 15.Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev. 2001;15 (8):995–1006. doi: 10.1101/gad.873501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jetten AM, Kurebayashi S, Ueda E. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol. 2001;69:205–247. doi: 10.1016/s0079-6603(01)69048-2. [DOI] [PubMed] [Google Scholar]
  • 17.Obrietan K, Impey S, Smith D, Athos J, Storm DR. Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem. 1999;274 (25):17748–17756. doi: 10.1074/jbc.274.25.17748. [DOI] [PubMed] [Google Scholar]
  • 18.Buhr ED, Takahashi JS. Molecular components of the Mammalian circadian clock. Handb Exp Pharmacol. 2013;(217):3–27. doi: 10.1007/978-3-642-25950-0_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Brown SA, Azzi A. Peripheral circadian oscillators in mammals. Handb Exp Pharmacol. 2013;(217):45–66. doi: 10.1007/978-3-642-25950-0_3. [DOI] [PubMed] [Google Scholar]
  • 20.Bozek K, Relogio A, Kielbasa SM, Heine M, Dame C, Kramer A, Herzel H. Regulation of clock-controlled genes in mammals. PLoS One. 2009;4 (3):e4882. doi: 10.1371/journal.pone.0004882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kumaki Y, Ukai-Tadenuma M, Uno KD, Nishio J, Masumoto KH, Nagano M, Komori T, Shigeyoshi Y, Hogenesch JB, Ueda HR. Analysis and synthesis of high-amplitude Cis-elements in the mammalian circadian clock. Proc Natl Acad Sci USA. 2008;105(39):14946–14951. doi: 10.1073/pnas.0802636105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bozek K, Kielbasa SM, Kramer A, Herzel H. Promoter analysis of Mammalian clock controlled genes. Genome Inform. 2007;18:65–74. [PubMed] [Google Scholar]
  • 23.Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, Gant TW, Hastings MH, Kyriacou CP. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol. 2002;12 (7):540–550. doi: 10.1016/s0960-9822(02)00759-5. [DOI] [PubMed] [Google Scholar]
  • 24.Kornmann B, Preitner N, Rifat D, Fleury-Olela F, Schibler U. Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. Nucleic Acids Res. 2001;29 (11):E51. doi: 10.1093/nar/29.11.e51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci USA. 2007;104(9):3342–3347. doi: 10.1073/pnas.0611724104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 2002;109 (3):307–320. doi: 10.1016/s0092-8674(02)00722-5. [DOI] [PubMed] [Google Scholar]
  • 27.Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002;417 (6884):78–83. doi: 10.1038/nature744. [DOI] [PubMed] [Google Scholar]
  • 28.Storch KF, Paz C, Signorovitch J, Raviola E, Pawlyk B, Li T, Weitz CJ. Intrinsic circadian clock of the mammalian retina: importance for retinal processing of visual information. Cell. 2007;130 (4):730–741. doi: 10.1016/j.cell.2007.06.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Leonardson AS, Zhu J, Chen Y, Wang K, Lamb JR, Reitman M, Emilsson V, Schadt EE. The effect of food intake on gene expression in human peripheral blood. Hum Mol Genet. 2010;19 (1):159–169. doi: 10.1093/hmg/ddp476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, Evans SJ, Choudary PV, Cartagena P, Barchas JD, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci USA. 2013;110(24):9950–9955. doi: 10.1073/pnas.1305814110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lim AS, Srivastava GP, Yu L, Chibnik LB, Xu J, Buchman AS, Schneider JA, Myers AJ, Bennett DA, De Jager PL. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet. 2014;10 (11):e1004792. doi: 10.1371/journal.pgen.1004792. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 32.Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol. 2008;4 (10):e1000193. doi: 10.1371/journal.pcbi.1000193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Goriki A, Hatanaka F, Myung J, Kim JK, Yoritaka T, Tanoue S, Abe T, Kiyonari H, Fujimoto K, Kato Y, et al. A novel protein, CHRONO, functions as a core component of the mammalian circadian clock. PLoS Biol. 2014;12 (4):e1001839. doi: 10.1371/journal.pbio.1001839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Anafi RC, Lee Y, Sato TK, Venkataraman A, Ramanathan C, Kavakli IH, Hughes ME, Baggs JE, Growe J, Liu AC, et al. Machine learning helps identify CHRONO as a circadian clock component. PLoS Biol. 2014;12 (4):e1001840. doi: 10.1371/journal.pbio.1001840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gossan NC, Zhang F, Guo B, Jin D, Yoshitane H, Yao A, Glossop N, Zhang YQ, Fukada Y, Meng QJ. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res. 2014;42 (9):5765–5775. doi: 10.1093/nar/gku225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jouffe C, Cretenet G, Symul L, Martin E, Atger F, Naef F, Gachon F. The circadian clock coordinates ribosome biogenesis. PLoS Biol. 2013;11 (1):e1001455. doi: 10.1371/journal.pbio.1001455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, Liu X, Atwood A, Huss JW, III, Janes J, et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell. 2009;139 (1):199–210. doi: 10.1016/j.cell.2009.08.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Podobed PS, Kirby GM, Martino TA. Circadian Proteomics and Its Unique Advantage for Discovery of Biomarkers of Heart Disease. In: Man Tsz Kwong., editor. Proteomics - Human Diseases and Protein Functions. InTech; 2012. [Google Scholar]
  • 39.Mehra A, Baker CL, Loros JJ, Dunlap JC. Post-translational modifications in circadian rhythms. Trends Biochem Sci. 2009;34 (10):483–490. doi: 10.1016/j.tibs.2009.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Moller M, Lund-Andersen C, Rovsing L, Sparre T, Bache N, Roepstorff P, Vorum H. Proteomics of the photoneuroendocrine circadian system of the brain. Mass Spectrom Rev. 2010;29 (2):313–325. doi: 10.1002/mas.20237. [DOI] [PubMed] [Google Scholar]
  • 41.Mauvoisin D, Dayon L, Gachon F, Kussmann M. Proteomics and circadian rhythms: It’s all about signaling! Proteomics. 2014 doi: 10.1002/pmic.201400187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Klei L, Reitz P, Miller M, Wood J, Maendel S, Gross D, Waldner T, Eaton J, Monk TH, Nimgaonkar VL. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int. 2005;22 (6):1041–1054. doi: 10.1080/07420520500397959. [DOI] [PubMed] [Google Scholar]
  • 43.Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, Mignot E. A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998;21 (6):569–576. doi: 10.1093/sleep/21.6.569. [DOI] [PubMed] [Google Scholar]
  • 44.Allebrandt KV, Amin N, Muller-Myhsok B, Esko T, Teder-Laving M, Azevedo RV, Hayward C, van MJ, Vogelzangs N, Green EW, et al. A K(ATP) channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila. Mol Psychiatry. 2013;18 (1):122–132. doi: 10.1038/mp.2011.142. [DOI] [PubMed] [Google Scholar]
  • 45.Silver R, Kriegsfeld LJ. Circadian rhythms have broad implications for understanding brain and behavior. Eur J Neurosci. 2014;39 (11):1866–1880. doi: 10.1111/ejn.12593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. J Clin Invest. 2011;121 (6):2133–2141. doi: 10.1172/JCI46043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Barclay JL, Husse J, Bode B, Naujokat N, Meyer-Kovac J, Schmid SM, Lehnert H, Oster H. Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One. 2012;7 (5):e37150. doi: 10.1371/journal.pone.0037150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res. 2010;106 (3):447–462. doi: 10.1161/CIRCRESAHA.109.208355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Froy O. Metabolism and circadian rhythms--implications for obesity. Endocr Rev. 2010;31 (1):1–24. doi: 10.1210/er.2009-0014. [DOI] [PubMed] [Google Scholar]
  • 50.Nagorny C, Lyssenko V. Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story? Curr Diab Rep. 2012;12 (6):667–672. doi: 10.1007/s11892-012-0327-y. [DOI] [PubMed] [Google Scholar]
  • 51.Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol. 2011;7 (1):29–36. doi: 10.1586/eci.10.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012;18:1249–1260. doi: 10.2119/molmed.2012.00077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593–628. doi: 10.1146/annurev.pharmtox.47.120505.105208. [DOI] [PubMed] [Google Scholar]
  • 54.Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol. 2011;57 (3):249–256. doi: 10.1016/j.jjcc.2011.02.006. [DOI] [PubMed] [Google Scholar]
  • 55.Lamont EW, Coutu DL, Cermakian N, Boivin DB. Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Relat Sci. 2010;47 (1):27–35. [PubMed] [Google Scholar]
  • 56.Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci. 2007;9 (3):333–342. doi: 10.31887/DCNS.2007.9.3/elamont. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010;11 (8):589–599. doi: 10.1038/nrn2868. [DOI] [PubMed] [Google Scholar]
  • 58.Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30 (7):873–880. doi: 10.1093/sleep/30.7.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262 (11):1479–1484. doi: 10.1001/jama.262.11.1479. [DOI] [PubMed] [Google Scholar]
  • 60.Roane BM, Taylor DJ. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep. 2008;31 (10):1351–1356. [PMC free article] [PubMed] [Google Scholar]
  • 61.Shibley HL, Malcolm RJ, Veatch LM. Adolescents with insomnia and substance abuse: consequences and comorbidities SHIBLEY2008. J Psychiatr Pract. 2008;14 (3):146–153. doi: 10.1097/01.pra.0000320113.30811.46. [DOI] [PubMed] [Google Scholar]
  • 62.Armstrong SM, Cassone VM, Chesworth MJ, Redman JR, Short RV. Synchronization of mammalian circadian rhythms by melatonin. J Neural Transm Suppl. 1986;21:375–394. [PubMed] [Google Scholar]
  • 63.de BC, Guardiola-Lemaitre B, Mocaer E, Renard P, Munoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9 (8):628–642. doi: 10.1038/nrd3140. [DOI] [PubMed] [Google Scholar]
  • 64.Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010;71 (2):109–120. doi: 10.4088/JCP.09m05347blu. [DOI] [PubMed] [Google Scholar]
  • 65.Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One. 2011;6 (8):e23982. doi: 10.1371/journal.pone.0023982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT, Lu L. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment LI2013. Psychoneuroendocrinology. 2013;38 (11):2789–2799. doi: 10.1016/j.psyneuen.2013.07.009. [DOI] [PubMed] [Google Scholar]
  • 67.Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA. 2007;104(15):6406–6411. doi: 10.1073/pnas.0609625104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Oliver PL, Sobczyk MV, Maywood ES, Edwards B, Lee S, Livieratos A, Oster H, Butler R, Godinho SI, Wulff K, et al. Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol. 2012;22 (4):314–319. doi: 10.1016/j.cub.2011.12.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Gorwood P. Anxiety disorders and circadian rhythms. Medicographia. 2012;34:289–294. [Google Scholar]
  • 70.Wong CC, Schumann G. Integration of the circadian and stress systems: influence of neuropeptides and implications for alcohol consumption. J Neural Transm. 2012;119 (10):1111–1120. doi: 10.1007/s00702-012-0829-4. [DOI] [PubMed] [Google Scholar]
  • 71.Landgraf D, McCarthy MJ, Welsh DK. Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep. 2014;16 (10):483. doi: 10.1007/s11920-014-0483-7. [DOI] [PubMed] [Google Scholar]
  • 72.Doi M, Yujnovsky I, Hirayama J, Malerba M, Tirotta E, Sassone-Corsi P, Borrelli E. Impaired light masking in dopamine D2 receptor-null mice DOI2006. Nat Neurosci. 2006;9 (6):732–734. doi: 10.1038/nn1711. [DOI] [PubMed] [Google Scholar]
  • 73.Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O’brien CP, Oslin DW, Lohoff FW, Berrettini WH. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet. 2014;78 (1):33–39. doi: 10.1111/ahg.12046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Li MD, Burmeister M. New insights into the genetics of addiction. Nat Rev Genet. 2009;10 (4):225–231. doi: 10.1038/nrg2536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Wang F, Simen A, Arias A, Lu QW, Zhang H. A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet. 2013;132 (3):347–358. doi: 10.1007/s00439-012-1251-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Olfson E, Bierut LJ. Convergence of genome-wide association and candidate gene studies for alcoholism. Alcohol Clin Exp Res. 2012;36 (12):2086–2094. doi: 10.1111/j.1530-0277.2012.01843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sipila T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, Auvinen P, Peltonen L, Lonnqvist J, Pirkola S, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry. 2010;67 (12):1163–1170. doi: 10.1016/j.biopsych.2009.12.011. [DOI] [PubMed] [Google Scholar]
  • 78.Wing YK, Zhang J, Lam SP, Li SX, Tang NL, Lai KY, Li AM. Familial aggregation and heritability of insomnia in a community-based study. Sleep Med. 2012;13 (8):985–990. doi: 10.1016/j.sleep.2012.04.013. [DOI] [PubMed] [Google Scholar]
  • 79.McCarren M, Goldberg J, Ramakrishnan V, Fabsitz R. Insomnia in Vietnam era veteran twins: influence of genes and combat experience. Sleep. 1994;17 (5):456–461. doi: 10.1093/sleep/17.5.456. [DOI] [PubMed] [Google Scholar]
  • 80.Watson NF, Goldberg J, Arguelles L, Buchwald D. Genetic and environmental influences on insomnia, daytime sleepiness, and obesity in twins. Sleep. 2006;29 (5):645–649. doi: 10.1093/sleep/29.5.645. [DOI] [PubMed] [Google Scholar]
  • 81.Palagini L, Biber K, Riemann D. The genetics of insomnia--evidence for epigenetic mechanisms? Sleep Med Rev. 2014;18 (3):225–235. doi: 10.1016/j.smrv.2013.05.002. [DOI] [PubMed] [Google Scholar]
  • 82.Manfredi RL, Brennan RW, Cadieux RJ. Disorders of excessive sleepiness: narcolepsy and hypersomnia. Semin Neurol. 1987;7 (3):250–258. doi: 10.1055/s-2008-1041425. [DOI] [PubMed] [Google Scholar]
  • 83.Buysse DJ. Insomnia. JAMA. 2013;309 (7):706–716. doi: 10.1001/jama.2013.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Longstreth WT, Jr, Koepsell TD, Ton TG, Hendrickson AF, van BG. The epidemiology of narcolepsy. Sleep. 2007;30 (1):13–26. doi: 10.1093/sleep/30.1.13. [DOI] [PubMed] [Google Scholar]
  • 85.Buhr A, Bianchi MT, Baur R, Courtet P, Pignay V, Boulenger JP, Gallati S, Hinkle DJ, Macdonald RL, Sigel E. Functional characterization of the new human GABA(A) receptor mutation beta3(R192H) Hum Genet. 2002;111 (2):154–160. doi: 10.1007/s00439-002-0766-7. [DOI] [PubMed] [Google Scholar]
  • 86.Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med. 2012;4 (161):161ra151. doi: 10.1126/scitranslmed.3004685. [DOI] [PubMed] [Google Scholar]
  • 87.Wurtman RJ. Narcolepsy and the hypocretins. Metabolism. 2006;55 (10 Suppl 2):S36–S39. doi: 10.1016/j.metabol.2006.07.011. [DOI] [PubMed] [Google Scholar]
  • 88.Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291 (5506):1040–1043. doi: 10.1126/science.1057499. [DOI] [PubMed] [Google Scholar]
  • 89.Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptacek LJ, Fu YH. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434 (7033):640–644. doi: 10.1038/nature03453. [DOI] [PubMed] [Google Scholar]
  • 90.Punia S, Rumery KK, Yu EA, Lambert CM, Notkins AL, Weaver DR. Disruption of gene expression rhythms in mice lacking secretory vesicle proteins IA-2 and IA-2beta. Am J Physiol Endocrinol Metab. 2012;303 (6):E762–E776. doi: 10.1152/ajpendo.00513.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Zhang EE, Kay SA. Clocks not winding down: unravelling circadian networks. Nat Rev Mol Cell Biol. 2010;11 (11):764–776. doi: 10.1038/nrm2995. [DOI] [PubMed] [Google Scholar]
  • 92.Byrne EM, Gehrman PR, Medland SE, Nyholt DR, Heath AC, Madden PA, Hickie IB, Van Duijn CM, Henders AK, Montgomery GW, et al. A genome-wide association study of sleep habits and insomnia. Am J Med Genet B Neuropsychiatr Genet. 2013;162B (5):439–451. doi: 10.1002/ajmg.b.32168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Hogl B, Berger K, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet. 2011;7 (7):e1002171. doi: 10.1371/journal.pgen.1002171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, Ripke S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet. 2008;40 (8):946–948. doi: 10.1038/ng.190. [DOI] [PubMed] [Google Scholar]
  • 95.Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Putz B, Eckstein G, Hauk S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39 (8):1000–1006. doi: 10.1038/ng2099. [DOI] [PubMed] [Google Scholar]
  • 96.Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, Palsson S, Sigmundsson T, Sigurdsson AP, Eiriksdottir I, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357 (7):639–647. doi: 10.1056/NEJMoa072743. [DOI] [PubMed] [Google Scholar]
  • 97.Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, Mayer G, Plazzi G, Nevsimalova S, Bourgin P, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41 (6):708–711. doi: 10.1038/ng.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Etain B, Jamain S, Milhiet V, Lajnef M, Boudebesse C, Dumaine A, Mathieu F, Gombert A, Ledudal K, Gard S, et al. Association between circadian genes, bipolar disorders and chronotypes. Chronobiol Int. 2014;31 (7):807–814. doi: 10.3109/07420528.2014.906445. [DOI] [PubMed] [Google Scholar]
  • 99.Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet. 2008;147B (7):1047–1055. doi: 10.1002/ajmg.b.30714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Kripke DF, Nievergelt CM, Tranah GJ, Murray SS, Rex KM, Grizas AP, Hahn EK, Lee HJ, Kelsoe JR, Kline LE. FMR1, circadian genes and depression: suggestive associations or false discovery? J Circadian Rhythms. 2013;11 (1):3. doi: 10.1186/1740-3391-11-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, Lichtermann D, Praschak-Rieder N, Neumeister A, Nilsson LG, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003;28 (4):734–739. doi: 10.1038/sj.npp.1300121. [DOI] [PubMed] [Google Scholar]
  • 102.Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, Aron L, Rietschel M, Wellek S, Soronen P, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med. 2007;39 (3):229–238. doi: 10.1080/07853890701278795. [DOI] [PubMed] [Google Scholar]
  • 103.Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lonnqvist J, Partonen T. Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol. 2010;45 (4):303–311. doi: 10.1093/alcalc/agq035. [DOI] [PubMed] [Google Scholar]
  • 104.Levran O, Londono D, O’Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, et al. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav. 2008;7 (7):720–729. doi: 10.1111/j.1601-183X.2008.00410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009;11 (7):701–710. doi: 10.1111/j.1399-5618.2009.00756.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, Gutierrez-Zotes A, Puigdemont D, Bayes M, Crespo JM, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology. 2010;35 (6):1279–1289. doi: 10.1038/npp.2009.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Utge SJ, Soronen P, Loukola A, Kronholm E, Ollila HM, Pirkola S, Porkka-Heiskanen T, Partonen T, Paunio T. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance. PLoS One. 2010;5 (2):e9259. doi: 10.1371/journal.pone.0009259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS One. 2012;7 (2):e32091. doi: 10.1371/journal.pone.0032091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Wetherill L, Agrawal A, Kapoor M, Bertelsen S, Bierut LJ, Brooks A, Dick D, Hesselbrock M, Hesselbrock V, Koller DL, et al. Association of substance dependence phenotypes in the COGA sample. Addict Biol. 2014 doi: 10.1111/adb.12153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Schosser A, Butler AW, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Gill M, Rice J, et al. Genome-wide association study of co-occurring anxiety in major depression. World J Biol Psychiatry. 2013;14 (8):611–621. doi: 10.3109/15622975.2013.782107. [DOI] [PubMed] [Google Scholar]
  • 111.Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45 (9):984–994. doi: 10.1038/ng.2711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Trzaskowski M, Eley TC, Davis OS, Doherty SJ, Hanscombe KB, Meaburn EL, Haworth CM, Price T, Plomin R. First genome-wide association study on anxiety-related behaviours in childhood. PLoS One. 2013;8 (4):e58676. doi: 10.1371/journal.pone.0058676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Chen X, Cho K, Singer BH, Zhang H. The nuclear transcription factor PKNOX2 is a candidate gene for substance dependence in European-origin women. PLoS One. 2011;6 (1):e16002. doi: 10.1371/journal.pone.0016002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature. 2003;421 (6919):177–182. doi: 10.1038/nature01314. [DOI] [PubMed] [Google Scholar]
  • 115.Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006;125 (3):497–508. doi: 10.1016/j.cell.2006.03.033. [DOI] [PubMed] [Google Scholar]
  • 116.Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, Sassone-Corsi P. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature. 2007;450 (7172):1086–1090. doi: 10.1038/nature06394. [DOI] [PubMed] [Google Scholar]
  • 117.Johansson AS, Brask J, Owe-Larsson B, Hetta J, Lundkvist GB. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J Biol Rhythms. 2011;26 (6):541–551. doi: 10.1177/0748730411419775. [DOI] [PubMed] [Google Scholar]
  • 118.Alenghat T, Meyers K, Mullican SE, Leitner K, iji-Adele A, Avila J, Bucan M, Ahima RS, Kaestner KH, Lazar MA. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature. 2008;456 (7224):997–1000. doi: 10.1038/nature07541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, Liu XS, Lazar MA. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science. 2011;331 (6022):1315–1319. doi: 10.1126/science.1198125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008;134 (2):317–328. doi: 10.1016/j.cell.2008.06.050. [DOI] [PubMed] [Google Scholar]
  • 121.Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron. 2008;58 (1):10–14. doi: 10.1016/j.neuron.2008.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell. 2013;153 (7):1448–1460. doi: 10.1016/j.cell.2013.05.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, Allard JS, Lewis K, Miller M, Xu W, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 2010;30 (29):9695–9707. doi: 10.1523/JNEUROSCI.0027-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466 (7310):1105–1109. doi: 10.1038/nature09271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.DiTacchio L, Le HD, Vollmers C, Hatori M, Witcher M, Secombe J, Panda S. Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Science. 2011;333 (6051):1881–1885. doi: 10.1126/science.1206022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Bonsch D, Hothorn T, Krieglstein C, Koch M, Nehmer C, Lenz B, Reulbach U, Kornhuber J, Bleich S. Daily variations of homocysteine concentration may influence methylation of DNA in normal healthy individuals. Chronobiol Int. 2007;24 (2):315–326. doi: 10.1080/07420520701290565. [DOI] [PubMed] [Google Scholar]
  • 127.Krishna SM, Dear A, Craig JM, Norman PE, Golledge J. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis. 2013;228 (2):295–305. doi: 10.1016/j.atherosclerosis.2013.02.019. [DOI] [PubMed] [Google Scholar]
  • 128.Azzi A, Dallmann R, Casserly A, Rehrauer H, Patrignani A, Maier B, Kramer A, Brown SA. Circadian behavior is light-reprogrammed by plastic DNA methylation. Nat Neurosci. 2014;17 (3):377–382. doi: 10.1038/nn.3651. [DOI] [PubMed] [Google Scholar]
  • 129.Massart R, Freyburger M, Suderman M, Paquet J, El HJ, Belanger-Nelson E, Rachalski A, Koumar OC, Carrier J, Szyf M, et al. The genome-wide landscape of DNA methylation and hydroxymethylation in response to sleep deprivation impacts on synaptic plasticity genes. Transl Psychiatry. 2014;4:e347. doi: 10.1038/tp.2013.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Chen R, D’Alessandro M, Lee C. miRNAs are required for generating a time delay critical for the circadian oscillator. Curr Biol. 2013;23 (20):1959–1968. doi: 10.1016/j.cub.2013.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, Nakazawa T, Shimizu K, Okamura H, Impey S, et al. microRNA modulation of circadian-clock period and entrainment. Neuron. 2007;54 (5):813–829. doi: 10.1016/j.neuron.2007.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.varez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C, Sonenberg N, Cheng HY. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet. 2011;20 (4):731–751. doi: 10.1093/hmg/ddq519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Coon SL, Munson PJ, Cherukuri PF, Sugden D, Rath MF, Moller M, Clokie SJ, Fu C, Olanich ME, Rangel Z, et al. Circadian changes in long noncoding RNAs in the pineal gland. Proc Natl Acad Sci USA. 2012;109(33):13319–13324. doi: 10.1073/pnas.1207748109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Xue Z, Ye Q, Anson SR, Yang J, Xiao G, Kowbel D, Glass NL, Crosthwaite SK, Liu Y. Transcriptional interference by antisense RNA is required for circadian clock function. Nature. 2014 doi: 10.1038/nature13671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Hughes ME, Grant GR, Paquin C, Qian J, Nitabach MN. Deep sequencing the circadian and diurnal transcriptome of Drosophila brain HUGHES2012. Genome Res. 2012;22 (7):1266–1281. doi: 10.1101/gr.128876.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Johnsson P, Lipovich L, Grander D, Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta. 2014;1840 (3):1063–1071. doi: 10.1016/j.bbagen.2013.10.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Pang KC, Frith MC, Mattick JS. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet. 2006;22 (1):1–5. doi: 10.1016/j.tig.2005.10.003. [DOI] [PubMed] [Google Scholar]
  • 138.Fustin JM, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155 (4):793–806. doi: 10.1016/j.cell.2013.10.026. [DOI] [PubMed] [Google Scholar]
  • 139.Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, Grove K, Lane R, agaard-Tillery K. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 2011;25 (2):714–726. doi: 10.1096/fj.10-172080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Ciarleglio CM, Axley JC, Strauss BR, Gamble KL, McMahon DG. Perinatal photoperiod imprints the circadian clock CIARLEGLIO2011. Nat Neurosci. 2011;14 (1):25–27. doi: 10.1038/nn.2699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Chavez SL, McElroy SL, Bossert NL, De Jonge CJ, Rodriguez MV, Leong DE, Behr B, Westphal LM, Reijo Pera RA. Comparison of epigenetic mediator expression and function in mouse and human embryonic blastomeres. Hum Mol Genet. 2014;23 (18):4970–4984. doi: 10.1093/hmg/ddu212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Moller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, Lo JC, Santhi N, von SM, Smith CP, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA. 2013;110(12):E1132–E1141. doi: 10.1073/pnas.1217154110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Archer SN, Laing EE, Moller-Levet CS, van d V, Bucca G, Lazar AS, Santhi N, Slak A, Kabiljo R, von SM, et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci USA. 2014;111(6):E682–E691. doi: 10.1073/pnas.1316335111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, Rota F, Costa G. Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol Int. 2010;27 (5):1093–1104. doi: 10.3109/07420528.2010.490065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Dykens E, Shah B. Psychiatric disorders in Prader-Willi syndrome: epidemiology and management. CNS Drugs. 2003;17 (3):167–178. doi: 10.2165/00023210-200317030-00003. [DOI] [PubMed] [Google Scholar]
  • 146.Sahoo T, del GD, German JR, Shinawi M, Peters SU, Person RE, Garnica A, Cheung SW, Beaudet AL. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008;40 (6):719–721. doi: 10.1038/ng.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Powell WT, Coulson RL, Crary FK, Wong SS, Ach RA, Tsang P, Alice YN, Yasui DH, Lasalle JM. A Prader-Willi locus lncRNA cloud modulates diurnal genes and energy expenditure. Hum Mol Genet. 2013;22 (21):4318–4328. doi: 10.1093/hmg/ddt281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Saus E, Soria V, Escaramis G, Vivarelli F, Crespo JM, Kagerbauer B, Menchon JM, Urretavizcaya M, Gratacos M, Estivill X. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum Mol Genet. 2010;19 (20):4017–4025. doi: 10.1093/hmg/ddq316. [DOI] [PubMed] [Google Scholar]
  • 149.Grennan KS, Chen C, Gershon ES, Liu C. Molecular network analysis enhances understanding of the biology of mental disorders. Bioessays. 2014;36 (6):606–616. doi: 10.1002/bies.201300147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Hayes KR, Baggs JE, Hogenesch JB. Circadian clocks are seeing the systems biology light. Genome Biol. 2005;6 (5):219. doi: 10.1186/gb-2005-6-5-219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Patel VR, Eckel-Mahan K, Sassone-Corsi P, Baldi P. CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics. Nat Methods. 2012;9 (8):772–773. doi: 10.1038/nmeth.2111. [DOI] [PubMed] [Google Scholar]
  • 152.Ukai H, Ueda HR. Systems biology of mammalian circadian clocks. Annu Rev Physiol. 2010;72:579–603. doi: 10.1146/annurev-physiol-073109-130051. [DOI] [PubMed] [Google Scholar]
  • 153.McDonald MJ, Rosbash M. Microarray analysis and organization of circadian gene expression in Drosophila. Cell. 2001;107 (5):567–578. doi: 10.1016/s0092-8674(01)00545-1. [DOI] [PubMed] [Google Scholar]
  • 154.Ueda HR. A systems-biological approach in drug discovery for circadian rhythm disorders. Nihon Yakurigaku Zasshi. 2002;120 (1):37P–40P. [PubMed] [Google Scholar]
  • 155.Zvonic S, Ptitsyn AA, Conrad SA, Scott LK, Floyd ZE, Kilroy G, Wu X, Goh BC, Mynatt RL, Gimble JM. Characterization of peripheral circadian clocks in adipose tissues. Diabetes. 2006;55 (4):962–970. doi: 10.2337/diabetes.55.04.06.db05-0873. [DOI] [PubMed] [Google Scholar]
  • 156.Oster H, Damerow S, Hut RA, Eichele G. Transcriptional profiling in the adrenal gland reveals circadian regulation of hormone biosynthesis genes and nucleosome assembly genes. J Biol Rhythms. 2006;21 (5):350–361. doi: 10.1177/0748730406293053. [DOI] [PubMed] [Google Scholar]
  • 157.Lemos DR, Downs JL, Urbanski HF. Twenty-four-hour rhythmic gene expression in the rhesus macaque adrenal gland. Mol Endocrinol. 2006;20 (5):1164–1176. doi: 10.1210/me.2005-0361. [DOI] [PubMed] [Google Scholar]
  • 158.Zvonic S, Ptitsyn AA, Kilroy G, Wu X, Conrad SA, Scott LK, Guilak F, Pelled G, Gazit D, Gimble JM. Circadian oscillation of gene expression in murine calvarial bone. J Bone Miner Res. 2007;22 (3):357–365. doi: 10.1359/jbmr.061114. [DOI] [PubMed] [Google Scholar]
  • 159.Yang S, Wang K, Valladares O, Hannenhalli S, Bucan M. Genome-wide expression profiling and bioinformatics analysis of diurnally regulated genes in the mouse prefrontal cortex. Genome Biol. 2007;8 (11):R247. doi: 10.1186/gb-2007-8-11-r247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C, Hagenbuchle O, O’Hara BF, Franken P, Tafti M. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci USA. 2007;104(50):20090–20095. doi: 10.1073/pnas.0710131104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol. 2008;294 (2):H1036–H1047. doi: 10.1152/ajpheart.01291.2007. [DOI] [PubMed] [Google Scholar]
  • 162.Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 2003;4 (10):R61. doi: 10.1186/gb-2003-4-10-r61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Kronfeld-Schor N, Einat H. Circadian rhythms and depression: human psychopathology and animal models. Neuropharmacology. 2012;62 (1):101–114. doi: 10.1016/j.neuropharm.2011.08.020. [DOI] [PubMed] [Google Scholar]
  • 164.Mendlewicz J, Kerkhofs M. Sleep electroencephalography in depressive illness. A collaborative study by the World Health Organization. Br J Psychiatry. 1991;159:505–509. doi: 10.1192/bjp.159.4.505. [DOI] [PubMed] [Google Scholar]
  • 165.Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry. 1976;11 (2):159–174. [PubMed] [Google Scholar]
  • 166.Emens J, Lewy A, Kinzie JM, Arntz D, Rough J. Circadian misalignment in major depressive disorder. Psychiatry Res. 2009;168 (3):259–261. doi: 10.1016/j.psychres.2009.04.009. [DOI] [PubMed] [Google Scholar]
  • 167.Robillard R, Naismith SL, Hickie IB. Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder. Curr Psychiatry Rep. 2013;15 (10):402. doi: 10.1007/s11920-013-0402-3. [DOI] [PubMed] [Google Scholar]
  • 168.Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry. 2008;165 (7):830–843. doi: 10.1176/appi.ajp.2008.08010077. [DOI] [PubMed] [Google Scholar]
  • 169.Monk TH, Burk LR, Klein MH, Kupfer DJ, Soehner AM, Essex MJ. Behavioral circadian regularity at age 1 month predicts anxiety levels during school-age years. Psychiatry Res. 2010;178 (2):370–373. doi: 10.1016/j.psychres.2009.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Shibley HL, Malcolm RJ, Veatch LM. Adolescents with insomnia and substance abuse: consequences and comorbidities SHIBLEY2008. J Psychiatr Pract. 2008;14 (3):146–153. doi: 10.1097/01.pra.0000320113.30811.46. [DOI] [PubMed] [Google Scholar]
  • 171.Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci. 2000;25 (5):469–480. [PMC free article] [PubMed] [Google Scholar]
  • 172.Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression? Am J Psychiatry. 1992;149 (2):159–168. doi: 10.1176/ajp.149.2.159. [DOI] [PubMed] [Google Scholar]
  • 173.Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res. 1999;86 (3):267–270. doi: 10.1016/s0165-1781(99)00036-0. [DOI] [PubMed] [Google Scholar]
  • 174.Iwahana E, Hamada T, Uchida A, Shibata S. Differential effect of lithium on the circadian oscillator in young and old hamsters. Biochem Biophys Res Commun. 2007;354 (3):752–756. doi: 10.1016/j.bbrc.2007.01.042. [DOI] [PubMed] [Google Scholar]
  • 175.Demyttenaere K. Agomelatine in treating generalized anxiety disorder. Expert Opin Investig Drugs. 2014;23 (6):857–864. doi: 10.1517/13543784.2014.911840. [DOI] [PubMed] [Google Scholar]
  • 176.Stein DJ, Ahokas A, Marquez MS, Hoschl C, Oh KS, Jarema M, Avedisova AS, Albarran C, Olivier V. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry. 2014;75 (4):362–368. doi: 10.4088/JCP.13m08433. [DOI] [PubMed] [Google Scholar]
  • 177.Mansour HA, Wood J, Chowdari KV, Dayal M, Thase ME, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL. Circadian phase variation in bipolar I disorder. Chronobiol Int. 2005;22 (3):571–584. doi: 10.1081/CBI-200062413. [DOI] [PubMed] [Google Scholar]
  • 178.Wood J, Birmaher B, Axelson D, Ehmann M, Kalas C, Monk K, Turkin S, Kupfer DJ, Brent D, Monk TH, et al. Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res. 2009;166 (2–3):201–209. doi: 10.1016/j.psychres.2008.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179.Broms U, Pennanen M, Patja K, Ollila H, Korhonen T, Kankaanpaa A, Haukkala A, Tuulio-Henriksson A, Koskenvuo M, Kronholm E, et al. Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study. J Addict Res Ther. 2012:S2. doi: 10.4172/2155-6105.s2-002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Adan A. Chronotype and personality factors in the daily consumption of alcohol and psychostimulants. Addiction. 1994;89 (4):455–462. doi: 10.1111/j.1360-0443.1994.tb00926.x. [DOI] [PubMed] [Google Scholar]
  • 181.Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, Houck PR, Kupfer DJ. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med. 2000;30 (5):1005–1016. doi: 10.1017/s0033291799002706. [DOI] [PubMed] [Google Scholar]
  • 182.Ashman SB, Monk TH, Kupfer DJ, Clark CH, Myers FS, Frank E, Leibenluft Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder. Psychiatry Res. 1999;86 (1):1–8. doi: 10.1016/s0165-1781(99)00019-0. [DOI] [PubMed] [Google Scholar]
  • 183.Malkoff-Schwartz S, Frank E, Anderson B, Sherrill JT, Siegel L, Patterson D, Kupfer DJ. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry. 1998;55 (8):702–707. doi: 10.1001/archpsyc.55.8.702. [DOI] [PubMed] [Google Scholar]
  • 184.Shear MK, Randall J, Monk TH, Ritenour A, Tu X, Frank E, Reynolds C, Kupfer DJ. Social rhythm in anxiety disorder patients. Anxiety. 1994;1 (2):90–95. doi: 10.1002/anxi.3070010208. [DOI] [PubMed] [Google Scholar]
  • 185.Cassidy F, Carroll BJ. Seasonal variation of mixed and pure episodes of bipolar disorder. J Affect Disord. 2002;68 (1):25–31. doi: 10.1016/s0165-0327(00)00325-6. [DOI] [PubMed] [Google Scholar]
  • 186.Silverstone T, Romans S, Hunt N, McPherson H. Is there a seasonal pattern of relapse in bipolar affective disorders? A dual northern and southern hemisphere cohort study. Br J Psychiatry. 1995;167 (1):58–60. doi: 10.1192/bjp.167.1.58. [DOI] [PubMed] [Google Scholar]
  • 187.Sandyk R, Kanofsky JD. Cocaine addiction: relationship to seasonal affective disorder. Int J Neurosci. 1992;64 (1–4):195–201. doi: 10.3109/00207459209000545. [DOI] [PubMed] [Google Scholar]
  • 188.Nurnberger JI, Jr, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau L, et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 2000;57 (6):572–579. doi: 10.1001/archpsyc.57.6.572. [DOI] [PubMed] [Google Scholar]
  • 189.Lewy AJ, Nurnberger JI, Jr, Wehr TA, Pack D, Becker LE, Powell RL, Newsome DA. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry. 1985;142 (6):725–727. doi: 10.1176/ajp.142.6.725. [DOI] [PubMed] [Google Scholar]
  • 190.Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun. 2004;18 (4):314–325. doi: 10.1016/j.bbi.2003.12.011. [DOI] [PubMed] [Google Scholar]
  • 191.Lovallo WR. Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol. 2006;59 (3):195–202. doi: 10.1016/j.ijpsycho.2005.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192.Gonzalez R. The relationship between bipolar disorder and biological rhythms. J Clin Psychiatry. 2014;75 (4):e323–e331. doi: 10.4088/JCP.13r08507. [DOI] [PubMed] [Google Scholar]
  • 193.Sipila T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, Auvinen P, Peltonen L, Lonnqvist J, Pirkola S, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry. 2010;67 (12):1163–1170. doi: 10.1016/j.biopsych.2009.12.011. [DOI] [PubMed] [Google Scholar]
  • 194.Blomeyer D, Buchmann AF, Lascorz J, Zimmermann US, Esser G, Desrivieres S, Schmidt MH, Banaschewski T, Schumann G, Laucht M. Association of PER2 genotype and stressful life events with alcohol drinking in young adults. PLoS One. 2013;8 (3):e59136. doi: 10.1371/journal.pone.0059136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Shumay E, Fowler JS, Wang GJ, Logan J, ia-Klein N, Goldstein RZ, Maloney T, Wong C, Volkow ND. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. Transl Psychiatry. 2012;2:e86. doi: 10.1038/tp.2012.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Dong L, Bilbao A, Laucht M, Henriksson R, Yakovleva T, Ridinger M, Desrivieres S, Clarke TK, Lourdusamy A, Smolka MN, et al. Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-induced alcohol drinking. Am J Psychiatry. 2011;168 (10):1090–1098. doi: 10.1176/appi.ajp.2011.10111579. [DOI] [PubMed] [Google Scholar]
  • 197.Comasco E, Nordquist N, Gokturk C, Aslund C, Hallman J, Oreland L, Nilsson KW. The clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents. Ups J Med Sci. 2010;115 (1):41–48. doi: 10.3109/03009731003597127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198.Malison RT, Kranzler HR, Yang BZ, Gelernter J. Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet. 2006;16 (6):245–249. doi: 10.1097/01.ypg.0000242198.59020.ca. [DOI] [PubMed] [Google Scholar]
  • 199.Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med. 2005;11 (1):35–42. doi: 10.1038/nm1163. [DOI] [PubMed] [Google Scholar]
  • 200.Chung S, Lee EJ, Yun S, Choe HK, Park SB, Son HJ, Kim KS, Dluzen DE, Lee I, Hwang O, et al. Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell. 2014;157 (4):858–868. doi: 10.1016/j.cell.2014.03.039. [DOI] [PubMed] [Google Scholar]
  • 201.Spencer S, Falcon E, Kumar J, Krishnan V, Mukherjee S, Birnbaum SG, McClung CA. Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. Eur J Neurosci. 2013;37 (2):242–250. doi: 10.1111/ejn.12010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202.Logan RW, Williams WP, III, McClung CA. Circadian rhythms and addiction: mechanistic insights and future directions. Behav Neurosci. 2014;128 (3):387–412. doi: 10.1037/a0036268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203.Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT, Lu L. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment LI2013. Psychoneuroendocrinology. 2013;38 (11):2789–2799. doi: 10.1016/j.psyneuen.2013.07.009. [DOI] [PubMed] [Google Scholar]
  • 204.Iwahana E, Akiyama M, Miyakawa K, Uchida A, Kasahara J, Fukunaga K, Hamada T, Shibata S. Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci. 2004;19 (8):2281–2287. doi: 10.1111/j.0953-816X.2004.03322.x. [DOI] [PubMed] [Google Scholar]
  • 205.Padiath QS, Paranjpe D, Jain S, Sharma VK. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int. 2004;21 (1):43–55. doi: 10.1081/cbi-120027981. [DOI] [PubMed] [Google Scholar]
  • 206.Osland TM, Ferno J, Havik B, Heuch I, Ruoff P, Laerum OD, Steen VM. Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J Psychopharmacol. 2011;25 (7):924–933. doi: 10.1177/0269881110379508. [DOI] [PubMed] [Google Scholar]
  • 207.McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, Welsh DK. Genetic and clinical factors predict lithium’s effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry. 2013;3:e318. doi: 10.1038/tp.2013.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208.Akiyama M, Kirihara T, Takahashi S, Minami Y, Yoshinobu Y, Moriya T, Shibata S. Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum. Br J Pharmacol. 1999;128 (7):1616–1622. doi: 10.1038/sj.bjp.0702957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Honma K, Honma S. The SCN-independent clocks, methamphetamine and food restriction. Eur J Neurosci. 2009;30 (9):1707–1717. doi: 10.1111/j.1460-9568.2009.06976.x. [DOI] [PubMed] [Google Scholar]
  • 210.Gouin JP, Connors J, Kiecolt-Glaser JK, Glaser R, Malarkey WB, Atkinson C, Beversdorf D, Quan N. Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord. 2010;126 (1–2):161–166. doi: 10.1016/j.jad.2010.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES